Stay updated on Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial

Sign up to get notified when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    External reference links were added to the Study Results page, including PubMed articles (40753271, 40583275, 40583273, 40579547) and government information sites (hhs.gov, nih.gov, nlm.gov, ncbi.nlm.gov, usa.gov).
    Difference
    0.2%
    Check dated 2025-10-29T10:12:23.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    28 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-07T23:14:04.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Version bump: replacing v3.0.2 with v3.1.0 in the page metadata.
    Difference
    0.0%
    Check dated 2025-09-30T02:30:34.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Two new references about fordadistrogene movaparvovec in Duchenne muscular dystrophy were added, while the same two references were removed but replaced with online-ahead-of-print identifiers—resulting in a minor bibliographic update rather than a substantive page content change.
    Difference
    0.7%
    Check dated 2025-09-22T23:38:35.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Adds a new consolidated long-term safety study for movaparvovec recipients (C3391003) and marks the program as Terminated with revision v3.0.2 and dates 2025-08/15. Removes the outdated 'Active, not recruiting' status and the 'Back to Top' link.
    Difference
    0.8%
    Check dated 2025-09-15T19:20:24.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page has updated the publication date of a significant research article on AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy from June 27, 2025, to August 2025, and the version number has been revised from v3.0.0 to v3.0.1.
    Difference
    0.3%
    Check dated 2025-09-08T14:59:32.000Z thumbnail image

Stay in the know with updates to Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.